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Abstract
Hepatocellular carcinoma (HCC) is a deadly disease. Its incidence is rising worldwide 
without significant improvement in survival in spite of improving therapies. A wide 
array of treatment options for HCC exist and include surgery, catheter-based therapies, 
radiation and systemic therapy. These modalities are often used in combination for opti-
mal management in a multidisciplinary approach. Surgical resection remains one of the 
only curative therapeutic options for HCC, although it is indicated in select patients with 
localized disease. Herein, we cover the role of surgical resection in the management of 
HCC, reviewing the perioperative and operative considerations, in addition to highlight-
ing the advances in minimally invasive surgery and novel navigation technologies.
Keywords: hepatocellular carcinoma, liver cancer, surgery, minimally invasive, 
multidisciplinary
1. Introduction
Hepatocellular carcinoma (HCC) is the second most lethal malignancy worldwide [1]. Despite 
the advent of effective antiviral drugs to eradicate hepatitis C infection, the prevalence of HCC 
is projected to increase secondary to increasing rates of fatty liver disease from diabetes and 
the obesity epidemic [2]. Unfortunately, there has been little to no change in the survivability 
of HCC over the last three decades [3] in spite of the increasing array of therapeutic options, 
leaving much room for improvement. The armamentarium for managing HCC is wide and 
includes surgical resection, orthotopic liver transplantation (OLT), ablative techniques using 
ethanol (percutaneous ethanol injection, PEI), microwave (MWA) or radiofrequency (RFA), 
catheter-directed transarterial chemoembolization (TACE) or radioembolization (TARE), 
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external beam radiation therapy in the form of stereotactic body radiation therapy (SBRT) 
or proton beam therapy (PBT), systemic targeted small molecule tyrosine kinase inhibitors, 
check-point inhibitor immunotherapy and investigational agents. These modalities are often 
used together in a multidisciplinary approach.
Surgical resection, or partial hepatectomy (PH), is a potentially curative surgical treatment 
option for up to 15–20% of patients with HCC. The primary objective of PH is to remove the 
HCC with an adequate margin, while preserving as much functional liver parenchyma to 
avoid post-resection hepatic failure. With improvements in preoperative assessment, patient 
selection, surgical and anesthetic techniques, intraoperative ultrasound, PH for HCC is now 
routine and safe. Operative mortality has been reduced to less than 5% with a 5-year overall 
survival of 60–75%.
2. Preoperative considerations
Several factors are considered in determining the eligibility for PH, including the patient’s 
health status (e.g. age, ECOG PS), tumor-specific factors (e.g. extent and tumor biology), and 
the reserve of the liver remnant. Determined by the degree of liver dysfunction and the size 
of the postoperative liver remnant. While there is no strict age limit, one must consider the 
liver’s regenerative capabilities in elderly patients, and the patient’s ability to tolerate the 
physiologic consequences of portal pedicle clamping and acute hemorrhage on their cardio-
pulmonary system. In addition, patients undergoing a minimally invasive approach must 
also be able to endure the effects of the pneumoperitoneum and reverse Trendelenburg posi-
tioning on their physiology.
Several different clinical staging systems exist to stratify patients according to prognostic 
variables [4]. One of the most commonly used is the Barcelona Clinic Liver Cancer (BCLC) 
system which incorporates tumor size, number of nodules and hepatic function as classified 
by the Child-Pugh score [5]. The system classifies patients into early, intermediate, advanced 
and terminal stages and proposes recommended treatment strategy. According to this staging 
system, only stage 0 or early stage patients with small tumors are recommended for surgical 
resection or liver transplant.
However, many view the BCLC criterion for resection to be restrictive. For patients with large 
tumors (beyond any down-staging or expanded OLT criteria) who are ineligible for OLT, PH is 
the only potentially curative treatment. With improvements in perioperative management, pre-
operative morphological assessment and manipulation of the future liver remnant, PH for large 
HCC has been safely performed with good oncologic outcome [6, 7]. Therefore, large tumor 
size alone is not a contraindication to PH, rather factors such as multiple or bilobar tumors, 
extrahepatic metastasis, involvement of the main bile duct, portal venous or other macroscopic 
vascular invasion, and portal hypertension are all relative contraindications to PH. When 
clinically not evident, portal hypertension can be evaluated by measuring the transjugular 
intrahepatic portosystemic gradient (PSG). PSG values greater than 10 mmHg are indicative of 
significant portal hypertension and these patients must be approached with caution.
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85–90% of patients with HCC have concomitant liver dysfunction. It is critical to account for the 
degree of liver dysfunction in addition to the patient’s overall functional and nutritional status. 
Patients with liver disease are often malnourished with diminished performance status and 
comorbid conditions. To help stratify clinical liver dysfunction, patients are classified by the Child-
Turcotte-Pugh (CTP) score and the Model for End-Stage Liver Disease (MELD) system. These 
two systems classify patients based on physical exam and laboratory data, with increasing scores 
associated with higher overall surgical risk. In general, patients with CTP score up to B7, MELD 
score <9 without significant portal hypertension can be considered for PH. Patients with more 
severe liver dysfunction and HCC can be considered for OLT if they meet specific criteria [8, 9].
Assessment of the hepatic function and future liver remnant (FLR) is important for patient 
selection prior to surgical resection [10]. The volume of the FLR and the regenerative capac-
ity are key predictors of postoperative morbidity. Several laboratory tests have been used 
to evaluate hepatic reserve in cirrhotic patients including assessment of clearance of indo-
cyanine green, sorbitol and 99mTc-galactosyl serum albumin scintigraphy [11]. Preoperative 
volumetric analysis can be performed with 3D computerized tomography volumetry [12]. To 
minimize the chance of post-hepatectomy liver failure, data suggest a liver remnant to be at 
minimum >20% of preoperative liver volume in a normal functioning liver, >30% for patients 
who have undergone >3 months systemic chemotherapy and >40% in those with advanced 
liver disease [13, 14].
Several techniques for preoperative optimization of the FLR exist including portal vein embo-
lization (PVE) and the associated liver partition with portal vein ligation for staged hepa-
tectomy (ALPPS) [15]. Initially developed in 1986, PVE results in atrophy of the embolized 
segments and compensatory hypertrophy of the perfused segments [16], within approxi-
mately 4–6 weeks, with at least >10% growth of the FLR predicting adequate regeneration 
post-PH. PVE has been shown to reduce the rate of postoperative complications in select 
patients with chronic liver disease [17], and can also be used safely in patients undergoing 
concurrent chemotherapy for colorectal metastases. One study demonstrated improved prog-
nosis after PH in patients with impaired hepatic function [18].
ALPPS was developed in 2007 to induce liver hypertrophy in patients planned for extended 
liver resections with marginal FLR. A two-step operation, the initial data demonstrated it to 
be quite effective with rapid hypertrophy [15], however, it has not gained wide acceptance 
secondary to significant morbidity and mortality and the need for larger scale studies [19–21]. 
However, there are more recent reports of “mini-ALPPS” where the procedure is performed 
minimally invasively and with limited peripheral division of the parenchyma.
3. Surgical considerations
3.1. Surgical anatomy
The surgical anatomy of the liver is based on Claude Couinaud’s classification system and 
further refined in the Brisbane 2000 Terminology of Liver Anatomy and Resections (Figure 1) 
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[22]. In this classification, the liver is divided into first, second and third order divisions based 
on internal anatomy rather than surface landmarks. First order division splits the liver into 
a right and left hemiliver along Cantlie’s line, a plane extending from the middle of the gall-
bladder fossa to the center of the inferior vena cava. Second order divisions split the hemiliv-
ers into two respective sections or sectors, the medial and lateral sections/sectors on the left 
and anterior and posterior sections/sectors on the right. The third order division divides each 
section/sector into two segments, constituting the 9 individual hepatic segments defined by 
Couinaud. In general, each segment has a unique vascular inflow, outflow and biliary duct 
enabling segments to be removed without damage to other segments.
The proper hepatic artery and portal vein bifurcate prior to the hilum of the liver and form the 
right and left hepatic artery and portal vein which supply the right and left hemiliver. Joined 
by the biliary duct, the portal triad generally runs centrally within hepatic segments. The 
right hepatic artery enters the parenchyma soon after branching while the left has a longer 
extrahepatic course. In contrast, the three hepatic veins run between section/sectors in three 
portal scissurae. The right hepatic vein drains directly into the inferior vena cava (IVC) while 
the middle and left hepatic veins often form a common trunk prior to entering the IVC.
Figure 1. Schematic of liver anatomy separating the parenchyma into 9 anatomic segments. Each segment has unique 
blood supply and biliary drainage. Source: Cho, Fong. Hepatic Resection. In: Ashley SW, editor. Scientific American 
Surgery. Hamilton: Decker. 7th ed; 2014. pp. 1094–1114.
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The liver is encapsulated by a fibrous capsule, known as Glisson’s capsule. The capsule envel-
ops the portal triads as they enter the liver parenchyma which makes it identifiable on intra-
operative ultrasound. Furthermore, the dense capsule allows for control of the portal triad 
during dissection and enables pedicle ligation.
3.2. Anesthetic considerations
Some important perioperative anesthetic considerations should be accounted for to increase the 
safety of hepatectomy. To minimize the possibility of major intraoperative hemorrhage, the cen-
tral venous pressure should be maintained at less than 5 mmHg to reduce the intrahepatic venous 
pressure. This is achieved using various anesthetic maneuvers and agents such as IVF restriction, 
and administration of isoflurane, fentanyl, mannitol, and cisatricurium. For open hepatectomy, 
the patient can be placed in slight reverse Trendelenburg position if pressures allow and switched 
to Trendelenburg position if there is significant hemorrhage with hemodynamic derangement to 
increase cardiac output and maintain end-organ perfusion. For laparoscopic/robotic hepatectomy, 
the patient is placed in reverse Trendelenburg position for a caudal approach which improves 
visualization of the vasculature, and the pneumoperitoneum creates a tamponade effect on the 
hepatic veins, which aids in limiting hemorrhage. Adequate vascular access should be obtained 
using large bore IVs, with appropriate invasive hemodynamic monitoring using A-line. Blood 
products should be readily available and resuscitation of operative blood loss should be with an 
appropriate combination of crystalloid, albumin and blood product as necessary. End-tidal CO
2
 
is measured to monitor for CO
2
 embolism in the laparoscopic/robotic approach.
4. Operative technique
Resections are either “anatomic” or “non-anatomic”. Anatomic resection defines a resection 
that obeys Brisbane divisions and is preferred for malignant disease because it has been 
found to lower rate of positive margins, decrease regional recurrences and improve surgi-
cal outcome. Non-anatomic resection refers to parenchymal transection that does not respect 
segmental planes and is typically used for debulking procedures, benign tumors or when 
trying to preserve remnant parenchyma. Achieving a microscopic margin negative (R0) resec-
tion is paramount to reducing local recurrence. 1 cm surgical margins have historically been 
considered standard, but narrower margins have been safely demonstrated [23].
There are six standard, anatomic hepatic resections as defined by the Brisbane classification 
(Figure 2). Right hemi-hepatectomy consists of surgical resection of segments V-VIII and left 
hepatectomy includes segments II-IV and occasionally segment I. In an extended right hepa-
tectomy or a right trisectionectomy/trisectorectomy, segments IV-VIII, and in an extended 
left hepatectomy or a left trisectionectomy, segments II-IV, V and VIII are resected. A left 
lateral sectorectomy involves resection of segments II-III and a right posterior sectionectomy 
includes segments VI-VII. Segmentectomies denote resection of any individual segment.
The common principle of anatomic hepatectomies involves parenchymal transection after 
both vascular inflow and outflow have been controlled. Given that each hepatic segment has 
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their unique vascular inflow and outflow, each segment can be safely excised without dam-
age to surrounding hepatic segments. Intraoperative ultrasonography is used routinely for 
identification of the vascular structures, evaluation of tumor location, extent and relationship 
to the surrounding vasculature.
After initial laparoscopic inspection excludes unresectable disease (in selected cases), the 
incision is made. In an open conventional approach, appropriate incision and exposure is 
critical to safe hepatectomy. There are several incisions used including the bilateral subcostal 
(Chevron), right/left subcostal, J-type or the inverted Y (Mercedes) incision.
Once the liver is mobilized by dividing ligamentous attachments, careful inspection, palpa-
tion and ultrasound examination are performed to evaluate for any missed tumors. Arterial 
aberrancies are identified and portal triad inflow is controlled with sutures and clips or staple 
ligation. The corresponding hepatic vein is isolated and ligated. Parenchymal transection is 
performed along the line of devascularization. Different techniques for parenchymal transec-
tion exist, varying from clamp-crushing, waterjet, monopolar/bipolar cautery, radiofrequency 
ablative devices, bipolar vessel sealing devices, ultrasonic dissection devices to staplers. The 
clamp-crush technique is rapid and has been associated with lower rates of blood loss com-
pared to other methods [24]. Once the resected segment is removed, hemostasis is obtained 
Figure 2. Schematic illustrations of the standard hepatic resections as labeled. Source: Cho, Fong. Hepatic Resection. In: 
Ashley SW, editor. Scientific American Surgery. Hamilton: Decker. 7th ed; 2014. pp. 1094–1114.
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with sutures, clips, argon beam coagulator and application of various hemostatic agents. Biliary 
leaks are controlled with clipping and suture ligation. Prior to abdominal closure, drains are 
placed if there is an infected operative field or if a biliary reconstruction is performed [25].
5. Minimally invasive hepatectomy
5.1. Laparoscopic-assisted partial hepatectomy
Although established as a safe and beneficial approach for numerous intra-abdominal opera-
tions, laparoscopic techniques were slow to be adopted for liver surgery for several reasons 
[26]. Concerns over technical feasibility of vascular dissection and control, organ mobilization, 
parenchymal dissection and management of intraoperative complications were prohibitive. 
Furthermore, it was unknown if port-site seeding, inadequate margins and poor oncologic 
outcomes would be more common in the minimally invasive approach.
The benefits of laparoscopic liver surgery are numerous. In addition to the generalized benefits 
of laparoscopic surgery including a more rapid functional recovery, smaller incisions which 
reduce the incidence of surgical site infections and postoperative pulmonary complications, 
there are additional advantages specific to laparoscopic liver surgery. Steep Trendelenburg 
positioning reduces intrahepatic venous pressure and the pneumoperitoneum exerts tam-
ponade effect on vasculature leading to reduced intraoperative blood loss. Laparoscopy cre-
ates a caudal-cranial surgical view which affords improved visualization of major vascular 
structures compared to the ventral-dorsal angle of visualization of an open hepatectomy. For 
cirrhotic patients, small laparoscopic incisions avoid disruption of abdominal wall collater-
als and the constraint on fluid shifts in a laparoscopic partial hepatectomy can decrease the 
incidence of liver-related complications. Minimally invasive hepatectomy also results in less 
adhesion formation which facilitates additional surgery in the future.
There have been numerous studies to date demonstrating the safety and efficacy of lapa-
roscopic liver surgery. In 2009, a worldwide experience of 127 series including 2804 cases 
of laparoscopic partial hepatectomy demonstrated comparable 5-year overall survival 
and disease free survival compared to open hepatectomy [27]. Half of these cases were 
done for malignant disease with greater than 80% of resections boasting negative surgi-
cal margins. In 2015, a randomized control trial was published demonstrating safety and 
feasibility of laparoscopic liver resection with reduction in length of stay and intraopera-
tive blood loss compared to open hepatectomy [28]. Numerous systematic analyses have 
substantiated these data, demonstrating that the laparoscopic partial hepatectomy is 
associated with decreased intraoperative blood loss, shorter length of hospital stay, and 
decreased number of positive resection margins. Overall, there were consistently fewer 
complications found in the laparoscopic group in these reviews [29]. A case–control pro-
pensity matched studies also found no difference in 1-, 3-, and 5-year overall survival 
and disease-free survival [30]. The National Surgical Quality Improvement Program 
database was evaluated to compare short-term outcomes among patients undergoing 
minimally invasive partial hepatectomy. Over 3000 patients were include in the study 
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and it demonstrated lower postoperative morbidity and shorter length of stay compared 
with patients undergoing open liver resection [31].
Specific to the treatment of HCC, the safety and efficacy of the laparoscopic approach has 
been evaluated in several meta-analyses and propensity score analyses. These studies demon-
strated the equivalent or superior perioperative outcomes of laparoscopic compared to open 
resection [32, 33]. In a propensity score analysis, the overall and disease-free survival were 
similar and for the secondary outcomes, the laparoscopic group had shorter hospital stay, 
lower morbidity, with fewer transient liver failure and wound complications, and a larger 
tumor margin [34].
Multiple meta-analyses and case control series were reviewed and analyzed at the second 
international conference for laparoscopic liver resection in Morioka in 2014. Minor resections 
were validated as standard practice in the assessment stage, while major or complex resec-
tions were considered to be in the exploration stage, with incompletely defined risks. The Jury 
at Morioka made strong recommendations for higher quality studies including registries to 
define the role and benefits of laparoscopic major hepatectomy.
Patient selection is critical to ensuring safe laparoscopic partial hepatectomy. Although is 
technically feasible, resection of lesions in right posterior sections or the hepatic dome can 
be challenging and should be approached with caution. The patient is placed in the supine 
position and securely fastened to the table to allow for safe intraoperative repositioning. 
Generally, five ports are required for laparoscopic resection including two 12 mm and three 
5 mm ports. Port placement is dependent upon laterality of the lesion as shown in Figure 3. 
Some surgeons advocate using a hand access port to assist with intraoperative manipulation, 
intra-corporeal suturing as well as serve as the specimen removal site.
5.2. Robotic-assisted partial hepatectomy
Further advances in surgical technology has created new opportunities in minimally inva-
sive liver surgery. Robotic surgical systems offer unique advantages to the liver surgeon 
that enhances the minimally invasive approach. There are several key improvements on the 
robotic surgical system including a camera with optics providing a 3-dimensional stereotactic 
visual field. In addition, the instruments allow for seven degrees of freedom in their motion, 
providing easier suturing for hemorrhage control. There is no fulcrum effect on the body wall 
of the patient as in laparoscopic surgery, and it has been associated with reduction in surgeon 
fatigue compared to the laparoscopic approach.
Similar to laparoscopic partial hepatectomy, the patient is placed in the supine position and 
in steep reverse Trendelenburg position. The table is tilted with right side up approximately 
25 degrees for right-sided resections. Five ports are placed including four robot-controlled 
ports and one assistant port (Figure 4). The ports are placed based on the laterality of the 
resection. In general, for a right-sided hepatectomy, the camera port is placed to the right-side 
of midline. Once the ports have been placed, the robot is docked from the cephalad position 
(Figure 5). Intraoperative ultrasound is critical to establishing vascular anatomy and defining 
oncologic planes of resection. After vascular control and establishing the line of transection, 
parenchymal transection is performed using one of many published techniques [35].
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Several large case series have been published demonstrating the success of robotic liver resec-
tion [36, 37]. The first large case series of 70 patients included 38.5% major liver resections 
without any mortalities [36]. An early systematic review of the literature demonstrated safety 
and feasibility of the robotic technique, with conversion to open rate of 4.6% and complication 
rate of 20.3% [38]. In 2018, an international, multicenter retrospective review of robotic liver 
surgery was published specifically evaluating long-term oncologic outcomes in patients with 
primary hepatobiliary malignancies after a median follow up of 75 months [39]. This study 
demonstrated comparable outcomes between robotic, open and laparoscopic liver surgery 
with 3-year overall survival of 90% for HCC. The majority of the cases were non-anatomic 
resections with an R0 resection achieved in 95% of HCC resections, 68% in cholangiocarci-
noma and 82% in gallbladder cancer.
Minimally invasive approach to liver surgery, both laparoscopic and robotic-assisted, have their 
share of limitations. An important potential complication associated with the establishment of 
pneumoperitoneum and laparoscopic liver surgery is carbon dioxide gas embolism. Reports 
have demonstrated that this event rate is low, particularly if the pneumoperitoneal pressure is 
maintained below 12 mmHg [40]. Studies have published and event rate of as low as at 0.5~1.5% 
[41]. There is a learning curve with gaining proficiency in the laparoscopic technique of liver 
resection with expert centers estimating the learning curve for laparoscopic liver resection at 
approximately 45~70 cases with senior partner proctoring [42]. Other limitations include the need 
for a skilled bedside assistant, and the diminished tactile sense when dealing with friable tissue 
such as steatotic liver parenchyma or thin venules within a cirrhotic liver can make the case chal-
lenging. And in the rare event when massive venous bleeding ensues, it can be difficult to control.
Cost is one major barrier to the wide adoption of the robotic approach. There is a significant ini-
tial capital investment in addition to maintenance fees and costs of staff training. However, one 
Figure 3. Suggested port placements for laparoscopic left lateral sectionectomy (a) and hand-assisted laparoscopic right 
hepatectomy (b). Source: Cho, Fong. Hepatic Resection. In: Ashley SW, editor. Scientific American Surgery. Hamilton: 
Decker. 7th ed; 2014. pp. 1094–1114.
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study demonstrated that while perioperative costs are higher with the robot, the overall total 
direct hospital costs are lower at least in part due to the decrease length of stay with robotic 
minimally invasive resection [43]. There are several generations of the robot with older gen-
eration units best suited for an operation in a single work field, with cumbersome redocking 
steps to perform multi-quadrant operations. The majority of studies indicate a longer operating 
time secondary to robot set up and draping. Technically speaking, the robot does not provide 
haptic feedback challenging the surgeon to “feel with their eyes” and occasionally resulting in 
excessive tissue damage in inexperienced hands. Further studies are needed to examine the 
comparative effectiveness of robotic versus laparoscopic minimally invasive hepatectomy.
Figure 4. Image of port placement for a robot-assisted surgeries left lateral sectionectomy. Blue dots denote da Vinci 
8-mm reusable cannulas (3). Green dot denotes 12-mm camera port. Purple dot denotes AirSeal® assistant port. Costal 
margin and midline marked in dotted pen.
Figure 5. Standard operating room set up for robotic-assisted liver surgery. Head of bed is on left side of image, 
anesthesia equipment and personnel on right side of image.
Liver Cancer68
6. Postoperative complications
The main postoperative complications include postoperative hemorrhage, liver dysfunction, 
biliary leak and fluid collections. Postoperative hemorrhage is uncommon after liver resection 
if meticulous attention is given to confirmation of hemostasis at the conclusion of the case. 
Bleeding may occasionally occur from retroperitoneal structures, such as the adrenal gland, 
or diaphragmatic musculature. Argon beam coagulator and a variety of topical hemostatic 
applications are utilized to reduce liver surface related bleeding.
Post hepatectomy liver failure (PHLF) is a major postoperative complication with mortal-
ity of approximately 30%. The definition of post-hepatectomy liver is the impaired ability 
of the liver to maintain its synthetic, excretory and detoxifying functions, characterized by 
an increase in international normalized ratio and bilirubin on or after postoperative day 5 
[44]. The most effective treatment of PHLF is liver transplantation but that is reserved for 
the most severe cases. Initial care is supportive and often includes mechanical ventilation, 
hemodynamic support and hemodialysis. Administration of colloid products and nutritional 
supplementation is also advocated.
The best way to treat post-hepatectomy liver failure is to prevent it. Preoperative weight loss, 
nutritional supplementation, careful preoperative selection and risk stratification are impor-
tant to minimize the risk of PHLF [10]. Intra-operatively, minimizing blood loss and blood 
transfusion, close attention to hemostasis and minimizing skeletonization of the hepatoduo-
denal ligament will lower risk of PHLF. In the postoperative period, recognizing and aggres-
sively treating postoperative hemorrhage, biliary obstructions or leaks and intra-abdominal 
infections will reduce the hepatic stress and likelihood of developing hepatic failure.
Postoperative fluid collections collect in the resected liver bed. These collections are varied in 
etiology but can include hematoma, seroma or biloma. They often to not result in symptoms, 
but occasionally they can cause pain or fullness requiring drainage. These collections also are 
at risk for infection and abscess formation. Biliary leakage from the raw surface of the resected 
liver can occur in up to 8% of patients after liver resection [45].
7. Emerging technologies
7.1. Near-infrared fluorescent imaging in hepatic surgery
New technologies continue to be developed to enhance minimally invasive liver surgery. One 
example is intra-operative near-infrared fluorescence (NIF) imaging. NIF imaging has become 
commonplace in many laparoscopic and robotic camera systems enabling the identification 
of various dyes, such as indocyanine green, injected preoperatively. Indocyanine green is a 
green dye that is preferentially metabolized by hepatocytes and excreted in the biliary tree. 
It lights up the biliary tree and has been utilized for robotic and laparoscopic assisted chole-
cystectomy. It has been more recently utilized to guide parenchymal dissection after vascular 
control by identifying perfused from poorly perfused hepatic parenchyma.
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7.2. Intelligent imaging in robotic-assisted surgery
Future directions within the realm of robotic liver surgery include the application of preop-
erative planning with virtual reality (VR) models and real-time augmented reality (AR) intra-
operative endoscopic overlays to aid with surgical navigation on da Vinci ® surgical systems. 
The current practice standard for operative planning involves preoperative cross-sectional 
imaging using contrast-enhanced, multiphase liver protocol computed tomography (CT) or 
magnetic resonance imaging (MRI) scans to evaluate the tumor’s extent (size and number) 
and location with respect to critical structures including the major vasculature and biliary 
architecture. Surgeons rely on years of training to develop the ability to mentally reconstruct 
2D images into a mental 3D model in order to preoperatively plan for a surgery while refer-
encing the 2D images intraoperatively.
Computer-based three-dimensional (3D) reconstructions of liver tumors have been shown 
to increase accuracy of tumor localization and precision of operative planning for liver 
surgery [46]. While useful for operative planning, intraoperative review of 2D images on 
a traditional PACS system requires diversion of attention away from the operative field. 
Intraoperative ultrasound is routinely used for real-time localization of liver tumors and 
Figure 6. Virtual 3D model of the liver. Porcine experimental model with implanted radiopaque tumor within the liver 
parenchyma. Preoperatively, CT images were obtained of the porcine liver with 3D segmented reconstructions created 
from the DICOM images. The 3D reconstructions can be viewed for preoperative planning with intuitive Surgical’s da 
Vinci® Surgical System.
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identification of vessels and biliary structures. However, its use is limited in minimally 
invasive liver surgery due to the need for an additional port site and the need to interpret the 
2D ultrasound images and mentally reconstruct the 3D anatomy being projected based on 
the orientation of the ultrasound probe. Preoperative planning with a VR model (Figure 6) 
and the application of AR endoscopic overlay (Figure 7) of patient-specific anatomy into 
the robotic surgical system could potentially improve surgical efficiency in real-time with 
intelligent surgical navigation.
AR may be developed to overlay accurate 3D reconstruction data onto the operative field 
itself, thereby eliminating the need to divert the attention from the operative field and to 
translate the 2D images into a 3D construct. These advancements with planning and guidance 
can potentially reduce the cognitive load burden on the surgeon. Augmented reality for spa-
tial recognition has been shown to improve localization accuracy in an experimental model 
of uterine myomectomy [47],and our recent experience has shown promise and feasibility in 
an experimental porcine liver model (Figures 1 and 2). Next steps in the application of VR 
and AR to hepatobiliary surgery include overcoming technical obstacles of continuous co-
registration to a mobile liver with tissue deformation while continuing to define the utility of 
the technology with patient education, tumor board evaluations, preoperative planning and 
intraoperative navigation.
Figure 7. Real-time endoscopic overlay of 3D reconstruction over the surgical field on the da Vinci ® Xi Surgical System. 
The relationship between the tumor (light pink) and adjacent vasculature including the hepatic veins (light blue), hepatic 
arteries (red) and portal veins (blue) is present on the overlay. After initial registration, the overlay is mapped onto the 
patient-specific anatomy changing in real-time with camera movement.
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8. Conclusion
Hepatocellular carcinoma (HCC) is a deadly disease that represents major challenges for 
patients and healthcare providers alike. Numerous therapeutic options exist for the treatment 
of HCC that are often used in combination for local and regional control. Surgical resection 
remains an important intervention that can be curative. Minimally invasive surgical technolo-
gies continue to improve increasing its safety and applicability for oncologic liver surgery.
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